Go offline with the Player FM app!
Inside Mass Tort Litigation with Marcus Susen
Manage episode 363639799 series 2119562
The public often has a negative perception of attorneys, especially plaintiffs attorneys. What many don’t know is the crucial role plaintiffs attorneys play in championing the rights of everyday people, often against incredible odds.
In this episode of The David vs. Goliath Podcast, Matt Dolman and Stan Gipe welcome Marcus Susen, of Susen Law Group, where they discuss the legal intricacies of mass tort cases, the challenges plaintiffs' attorneys face when taking on contingency fees, and the need for effective leadership structures to manage the claims of those impacted.
Marcus also shares a compelling perspective on corporations' treatment in the legal system, the challenges faced by plaintiffs' attorneys, and the limitations of the FDA and the government when it comes to protecting consumers.
In this episode:
- [01:14] Getting into leadership in the mass tort litigation space: Marcus shares how he started, the competition, and his journey to get to where he is today.
- [04:00] Mass tort case consolidation and leadership: What it means to be in leadership, the costs, risks involved, and case examples.
- [09:34] Hopes for quicker resolution of Camp Lejeune claims: The Navy is urged to settle a large number of claims related to the Camp Lejeune injuries.
- [16:46] Vapor study from ATSDR: Data from Agency for Toxic Substances and Disease Registry could potentially support claims for additional injuries in the future.
- [19:02] Optimism about Camp Lejeune case serving as a model for other mass litigations: Marcus urges cooperation and data sharing to help resolve other similar cases.
- [19:41] AFFF and PFAS: Shedding light on the risks posed by these chemicals and their widespread presence in our lives.
- [21:51] Exploring litigation tracks and Bellwether cases: These cases involve the city of Stewart which holds significant implications for both municipalities and individual plaintiffs, setting the stage for potential settlements and shaping the future direction of the litigation.
- [24:35] Unveiling the AFFF Cases: They cover the number of cases, the upcoming bellwether trial, strength of scientific evidence and the impact of the chemicals to firefighters and military personnel.
- [27:44] Unmasking the forever chemicals sources: Understanding which companies are involved in its making and the truth about PFAS and their environmental impact.
- [33:41] Positive change through litigation: Explore the crucial role of plaintiffs attorneys in holding corporations accountable and ensuring consumer safety by initiating recalls and product liability lawsuits, shedding light on corporate wrongdoing.
- [35:01] FDA, big pharma, and medical device litigation: The questionable ties between FDA and Big Pharma as well as the complexities of medical device litigation, highlighting the Essure and Paragard cases as examples.
The insights and views presented in this podcast are for general information purposes only and should not be taken as legal advice for any individual case or situation. The information presented is not a substitute for consulting with an attorney. Nor does tuning in to this podcast constitute an attorney-client relationship of any kind. Any case result information provided on any portion of this podcast should not be understood as a promise of any particular result in a future case. Dolman Law Group Accident Injury Lawyers: Big firm results, small firm personal attention.
86 episodes
Manage episode 363639799 series 2119562
The public often has a negative perception of attorneys, especially plaintiffs attorneys. What many don’t know is the crucial role plaintiffs attorneys play in championing the rights of everyday people, often against incredible odds.
In this episode of The David vs. Goliath Podcast, Matt Dolman and Stan Gipe welcome Marcus Susen, of Susen Law Group, where they discuss the legal intricacies of mass tort cases, the challenges plaintiffs' attorneys face when taking on contingency fees, and the need for effective leadership structures to manage the claims of those impacted.
Marcus also shares a compelling perspective on corporations' treatment in the legal system, the challenges faced by plaintiffs' attorneys, and the limitations of the FDA and the government when it comes to protecting consumers.
In this episode:
- [01:14] Getting into leadership in the mass tort litigation space: Marcus shares how he started, the competition, and his journey to get to where he is today.
- [04:00] Mass tort case consolidation and leadership: What it means to be in leadership, the costs, risks involved, and case examples.
- [09:34] Hopes for quicker resolution of Camp Lejeune claims: The Navy is urged to settle a large number of claims related to the Camp Lejeune injuries.
- [16:46] Vapor study from ATSDR: Data from Agency for Toxic Substances and Disease Registry could potentially support claims for additional injuries in the future.
- [19:02] Optimism about Camp Lejeune case serving as a model for other mass litigations: Marcus urges cooperation and data sharing to help resolve other similar cases.
- [19:41] AFFF and PFAS: Shedding light on the risks posed by these chemicals and their widespread presence in our lives.
- [21:51] Exploring litigation tracks and Bellwether cases: These cases involve the city of Stewart which holds significant implications for both municipalities and individual plaintiffs, setting the stage for potential settlements and shaping the future direction of the litigation.
- [24:35] Unveiling the AFFF Cases: They cover the number of cases, the upcoming bellwether trial, strength of scientific evidence and the impact of the chemicals to firefighters and military personnel.
- [27:44] Unmasking the forever chemicals sources: Understanding which companies are involved in its making and the truth about PFAS and their environmental impact.
- [33:41] Positive change through litigation: Explore the crucial role of plaintiffs attorneys in holding corporations accountable and ensuring consumer safety by initiating recalls and product liability lawsuits, shedding light on corporate wrongdoing.
- [35:01] FDA, big pharma, and medical device litigation: The questionable ties between FDA and Big Pharma as well as the complexities of medical device litigation, highlighting the Essure and Paragard cases as examples.
The insights and views presented in this podcast are for general information purposes only and should not be taken as legal advice for any individual case or situation. The information presented is not a substitute for consulting with an attorney. Nor does tuning in to this podcast constitute an attorney-client relationship of any kind. Any case result information provided on any portion of this podcast should not be understood as a promise of any particular result in a future case. Dolman Law Group Accident Injury Lawyers: Big firm results, small firm personal attention.
86 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.